News & Blog
Access 60 patients from MOSAIC’s 7,000-patient dataset to explore spatial omics and validate research ideas.
Our latest publication on spatial and single-cell omics, histology, and AI.
Benchmarking spatial omics platforms to understand tumor biology and guide technology selection for MOSAIC.
Researchers can now access multimodal spatial omics data from 15 bladder cancer patients via EGA.
Keeping a large-scale, multi-site project running smoothly.
Keeping a large-scale, multi-site project running smoothly.
MOSAIC partners discuss reaching 1,000 patients and the future of spatial omics research.
MOSAIC surpasses 1,000 patients across 7 cancers and 6 data modalities, capturing tumor complexity at scale.
Access 60 patients from MOSAIC’s 7,000-patient dataset to explore spatial omics and validate research ideas.
Going from discovery to validation.
600 patients, covering 5 cancer indications and 6 data modalities.
University of Pittsburgh become fifth hospital to generate spatial omics data from patients in the MOSAIC study.
MOSAIC featured in a panel session on machine learning and spatial biology.
Spatial omics article in Technology Review.
Read the article in BIO-IT World
Owkin and 10x Genomics partner to bring spatial omics and single-cell technologies to the MOSAIC project.
Spatial omics is transforming biology by revealing how molecules and cells interact within healthy and diseased tissues.
Spatial omics is transforming biology by revealing how molecules and cells interact within healthy and diseased tissues.
An unprecedented $50 million spatial atlas of cancer cells.
A study that aims at building the largest spatial and multiomics dataset in oncology.
A study that aims at building the largest spatial and multiomics dataset in oncology.
We spoke with Prof Miriam Merad, Director of the Precision Immunology Institute at Mount Sinai.
We spoke with Prof Miriam Merad, Director of the Precision Immunology Institute at Mount Sinai.
With Professor Olivier Elemento, Director of the Precision Medicine Center.
With Professor Olivier Elemento, Director of the Precision Medicine Center.
